Table 2. Overlapping pathways for targets of SM cocktails and OSKM.
Pathways | Cocktails | |||||||||
#1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | #10 | |
Pathways in cancer | * | * | * | * | ||||||
Chronic myeloid leukemia | * | * | * | * | ||||||
Prostate cancer | * | * | * | |||||||
Bladder cancer | * | |||||||||
Small cell lung cancer | * | |||||||||
Viral carcinogenesis | * | * | * | |||||||
HTLV-I infection | * | * | * | |||||||
Hepatitis B | * | * | * | |||||||
Epstein-Barr virus infection | * | |||||||||
p53 signaling pathway | * |
Dark gray color with (*) depicts overlaps with p < 0.05. Light gray depicts the pathways with insignificant overlaps (p > 0.05).